---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-012173"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2026-03-23T23:59:59+00:00"
generated_at: "2026-05-15T09:22:53.155903+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Intelligent Bio grants restricted shares to CEO/CFO/directors; updates ATM facility

## Summary
- CEO Harry Simeonidis and CFO Spiro Sakiris each receive 9,150 time-vesting and 21,350 performance-vesting restricted shares.
- Directors awarded 20,000 time-vesting shares; non-executive employees get 10,500 time-vesting and 24,500 performance-vesting shares.
- Total outstanding shares as of March 23, 2026: 2,001,173, reflecting grants and warrant exercises.
- Up to $3,966,316 in shares available for sale under existing ATM agreement with Ladenburg Thalmann; new prospectus supplement filed.
- Performance-vesting shares tied to clinical trial, FDA submission, and commercial milestones; vest over up to 10 years.

## SEC filing metadata
- accession: 0001493152-26-012173
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2026-03-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000149315226012173/0001493152-26-012173-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000149315226012173/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-012173
- JSON: https://secwatch.observer/filing/0001493152-26-012173.json
- Plain text: https://secwatch.observer/filing/0001493152-26-012173.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
